ArticleBritish journal of haematology2025

Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis.

Jacopo Mariotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.